Report #2851009

Received Jul 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 36 yrs
State: PA
Recovered: Unknown
Vaccinated: Jun 30, 2025
Onset: Jun 30, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	Z002626	—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional adverse event; A HCP called to report a TE for CAPVAXIVE. The HCP stated that sometime during 06/27/2025 through 07/09/2025 the CAPVAXIVE was exposed to a minimum temperature of 0C and a maximum of 9C, but the HCP was unable to confirm when the excursions occurred; Information has been received from Business Partner/CRO on 09-Jul-2025. This spontaneous report was received from an Other health professional and refers to a 36-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-Jun-2025, the patient started therapy with Pneumococcal 21-valent Conjugate Vaccine (lot #Z002626, expiration date: 04-Sep-2026) 0.5 mL for an unknown indication. This vaccine was exposed to a minimum temperature of 0 degree Celsius and a maximum of 9 degree Celsius (Improper storage of product in use). No additional adverse event was reported.; Reporter's Comments: